• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERATHON MEDICAL LYRETTE; TRANS-URETHRAL RF SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERATHON MEDICAL LYRETTE; TRANS-URETHRAL RF SYSTEM Back to Search Results
Model Number PR918
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Incontinence (1928)
Event Date 03/06/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient underwent a lyrette procedure for stress urinary incontinence.Immediately following the procedure, the patient reported that her incontinence had worsened.The patient's physician stated that a "incontinence" pessary was installed and the patient has seen a reduction in symptoms.On (b)(6) 2014, verathon's consulting physician contacted the patient's physician and was told that the patient has a follow-up visit in 3 months.
 
Manufacturer Narrative
Requested but exact weight was not provided.Not applicable, no follow up testing performed.Serial number not available, probes are discarded after use.Not available, requires serial number.Fda recall z-1404-2010, instructions for use (ifu) revision: because of complaints received by novasys of worsened stress incontinence symptoms 3-4 weeks after treatment, the instructions for use were revised to emphasize potential side effects.A field action notification letter was sent to all current customers (physicians) along with the revised instructions for use and patient information brochures.The company also updated physician information brochures and patient/physician dvds to include the information.This was shipped to physicians on august/september of 2009.The letter included notice that the instructions for use had reinforced language that one of the potential side effects of the renessa system (lyrette) is worsening incontinence following treatment.It also stated that women with a urethral length shorter than 2.5cm should not be treated with renessa.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LYRETTE
Type of Device
TRANS-URETHRAL RF SYSTEM
Manufacturer (Section D)
VERATHON MEDICAL
newark NJ
Manufacturer Contact
carmen wassell
20001 n. creek pkwy
bothell, WA 98011
4256295674
MDR Report Key3824473
MDR Text Key4402857
Report Number3022472-2014-00010
Device Sequence Number1
Product Code NVJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 03/14/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/06/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPR918
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-1404-2010
Patient Sequence Number1
Treatment
LOCAL ANESTHESIA; LYRETTE GENERATOR: MODEL #GN602
Patient Outcome(s) Disability;
Patient Age68 YR
-
-